June 5, 2012 – Last month, a motion was filed with the U.S. Judicial Panel on Multidistrict Litigation (MDL) to centralize the Pradaxa claims pending in the federal court system under one judge. If approved, this action would effectively consolidate all product liability lawsuits over Boehringer Ingelheim’s controversial anticoagulant that have been filed in U.S. district courts throughout the country.
Free Pradaxa Lawsuit Evaluation: If you or a loved one has been injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the problem?
In a motion filed on May 30, plaintiff Vera Lee Sellers asked that all federal Pradaxa claims be consolidated for pretrial proceedings before U.S. District Judge David R. Herndon in the Southern District of Illinois, where a number of the complaints are currently pending.
Although the number of Pradaxa lawsuits in the federal court system is still relatively small, Sellers’ attorneys estimate that 500 or more additional claims will be filed in the near future. All of the complaints accuse Boehringer of the same or similar wrongful conduct, alleging claims for:
- failure to warn
- design defect
- manufacturing defect
- breach of warranty
- conduct that imposes liability for the marketing and sale of Pradaxa
If the Pradaxa litigation is consolidated into an MDL, all cases filed in federal courts throughout the country will be transferred to Judge Herndon. MDLs are intended to serve the convenience of all parties involved, helping to reduce duplicative discovery and avoid inconsistent pretrial rulings from different courts. Although the lawsuits are handled in a coordinated manner, unlike class action claims, each complaint remains an individual case. If the MDL is unable to reach a settlement or otherwise resolve the claims during pretrial proceedings, each case would be remanded back to its original court jurisdiction to proceed as an individual trial.
In her motion for consolidation, Sellers contended that Judge Herndon was an ideal candidate to coordinate the MDL because of his extensive experience handling large, drug-related litigation. Herndon is currently overseeing the Yaz and Yasmin MDLs, which involve claims filed on behalf of women who suffered blood clot-related injuries after taking the controversial birth control pills. Since that MDL was initiated in October 2009, Judge Herndon has successfully facilitated hundreds of Yaz settlement agreements.
Pradaxa was manufactured to be a replacement for Coumadin (generic: warfarin), and is supposed to require less monitoring and be easier to use. However, warfarin can be quickly counteracted with a dose of Vitamin K when an internal bleeding problem occurs. This does not work with Pradaxa or any of the other newer generation of blood thinners such as Xarelto (generic: rivaroxaban).
According to research conducted by the Institute for Safe Medication Practices (ISMP), the FDA received hundreds of reports of Pradaxa side effects within weeks of the drug being approved by the U.S. Food & Drug Administration (FDA). The vast majority of these side effects involved severe internal bleeding problems in elderly patients. In total, the administration received over 300 complaints about Pradaxa in the last quarter of 2010 alone, compared to just 202 complaints involving warfarin.
Do I Have a Pradaxa Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Pradaxa lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Confidential Case Evaluation: Again, if you or a loved one was injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.